Alpert JE - Search Results

1

Early nonresponse to fluoxetine as a predictor of poor 8-week outcome.

Nierenberg AA, McLean NE, Alpert JE, Worthington JJ, Rosenbaum JF, Fava M. Nierenberg AA, et al. Among authors: alpert je. Am J Psychiatry. 1995 Oct;152(10):1500-3. doi: 10.1176/ajp.152.10.1500. Am J Psychiatry. 1995. PMID: 7573590 Clinical Trial.

2

Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.

Fava M, Alpert J, Nierenberg A, Lagomasino I, Sonawalla S, Tedlow J, Worthington J, Baer L, Rosenbaum JF. Fava M, et al. J Clin Psychopharmacol. 2002 Aug;22(4):379-87. doi: 10.1097/00004714-200208000-00008. J Clin Psychopharmacol. 2002. PMID: 12172337 Clinical Trial.

3

Melancholia and axis II comorbidity.

Tedlow J, Smith M, Neault N, Polania L, Alpert J, Nierenberg A, Fava M. Tedlow J, et al. Compr Psychiatry. 2002 Sep-Oct;43(5):331-5. doi: 10.1053/comp.2002.34631. Compr Psychiatry. 2002. PMID: 12216007 Clinical Trial.

4

Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.

Perlis RH, Iosifescu DV, Alpert J, Nierenberg AA, Rosenbaum JF, Fava M. Perlis RH, et al. Psychosomatics. 2004 May-Jun;45(3):224-9. doi: 10.1176/appi.psy.45.3.224. Psychosomatics. 2004. PMID: 15123848 Clinical Trial.

5

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.

Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF. Fava M, et al. J Clin Psychopharmacol. 2005 Oct;25(5):441-7. doi: 10.1097/01.jcp.0000178416.60426.29. J Clin Psychopharmacol. 2005. PMID: 16160619 Clinical Trial.

6

NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients.

Petersen T, Papakostas GI, Bottonari K, Iacoviello B, Alpert JE, Fava M, Nierenberg AA. Petersen T, et al. Among authors: alpert je. Psychiatry Res. 2002 Jan 31;109(1):9-16. doi: 10.1016/s0165-1781(01)00359-6. Psychiatry Res. 2002. PMID: 11850046 Clinical Trial.

7

Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression.

Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M. Alpert JE, et al. Ann Clin Psychiatry. 2002 Mar;14(1):33-8. doi: 10.1023/a:1015271927517. Ann Clin Psychiatry. 2002. PMID: 12046638 Clinical Trial.

8

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M. Perlis RH, et al. Among authors: alpert je. J Clin Psychopharmacol. 2002 Oct;22(5):474-80. doi: 10.1097/00004714-200210000-00006. J Clin Psychopharmacol. 2002. PMID: 12352270 Clinical Trial.

9

Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.

Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Spector AR, Alpert JE, Fava M, Nierenberg AA. Papakostas GI, et al. Among authors: alpert je. Compr Psychiatry. 2003 Jan-Feb;44(1):44-50. doi: 10.1053/comp.2003.50012. Compr Psychiatry. 2003. PMID: 12524635

10

Nortriptyline for treatment-resistant depression.

Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, Iacoviello BM, Worthington JJ, Tedlow J, Alpert JE, Fava M. Nierenberg AA, et al. Among authors: alpert je. J Clin Psychiatry. 2003 Jan;64(1):35-9. doi: 10.4088/jcp.v64n0108. J Clin Psychiatry. 2003. PMID: 12590621 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page